Medications

New ALS drug approved in Canada while still under FDA review

An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness.

Medications

Opioid crisis roadmap overlooks gender

Women's Health Research at Yale (WHRY) is calling on a government committee to revise its report on a coordinated response to the opioid epidemic so that it reflects the unique needs of women.